Lifeward Ltd. (LFWD)
NASDAQ: LFWD · Real-Time Price · USD
1.500
+0.010 (0.67%)
At close: Dec 20, 2024, 4:00 PM
1.590
+0.090 (6.00%)
After-hours: Dec 20, 2024, 7:28 PM EST

Company Description

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.

It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.

The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors.

The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024.

Lifeward Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

Lifeward Ltd.
Lifeward logo
Country Israel
Founded 2001
IPO Date Sep 12, 2014
Industry Medical Devices
Sector Healthcare
Employees 108
CEO Lawrence Jasinski

Contact Details

Address:
3 Hatnufa Street, Floor 6
Yokneam Illit, 2069203
Israel
Phone 972 4 959 0123
Website golifeward.com

Stock Details

Ticker Symbol LFWD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001607962
ISIN Number IL0011331076
SIC Code 3842

Key Executives

Name Position
Lawrence J. Jasinski BS, MBA Chief Executive Officer and Director
Michael A. Lawless Chief Financial Officer
Miri Pariente Vice President of Operations, Regulatory and Quality
Almog Adar Vice President of Finance and Chief Accounting Officer
Jeannine Lynch Vice President of Market Access and Strategy
Kathleen O'Donnell Vice President of Marketing and New Business Development
Judy Kula Vice President of Customer Service, Human Resources and Business Affairs

Latest SEC Filings

Date Type Title
Nov 25, 2024 DEF 14A Other definitive proxy statements
Nov 15, 2024 PRE 14A Other preliminary proxy statements
Nov 12, 2024 10-Q Quarterly Report
Nov 12, 2024 8-K Current Report
Nov 7, 2024 8-K Current Report
Sep 16, 2024 144 Filing
Sep 4, 2024 8-K Current Report
Aug 26, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Aug 15, 2024 8-K Current Report
Aug 14, 2024 10-Q Quarterly Report